Sakanaka K, Sasaki K, Tsushima T, Machida R, et al. Study protocol of a randomized controlled phase II trial comparing nivolumab, ipilimumab plus radiotherapy versus nivolumab plus ipilimumab for advanced or recurrent esophageal cancer: Japan Clinical Oncology Group study JCOG2311 (ART NOUVEAU). BMC Cancer 2025 Dec 3. doi: 10.1186/s12885-025-15403.
PMID: 41331921